Heart failure with mid-range or mildly reduced ejection fraction | Nature Reviews Cardiology
PDF) Promoting psychosocial well-being following stroke: Study protocol for a randomized, controlled trial
W. Taylor Kimberly - Center for Genomic Medicine
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial | JACC: Heart Failure
Neurocritical Care Updates in Cerebrovascular Disease | Stroke
![PDF] Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ff2a649ad2496775a497804af4658a751daade79/3-Figure2-1.png "PDF] Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Semantic Scholar")
PDF] Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial | Semantic Scholar
IV glyburide for the prevention of brain edema - Kimberly Lab
Empagliflozin in Heart Failure with a Preserved Ejection Fraction | NEJM
Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment: A HERMES Meta-Analysis | Stroke
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - The Lancet
Feinstein Institute to study experimental stroke drug | Northwell Health
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction (CHARM) > Clinical Trials > Yale Medicine
Myocardial Infarction in Heart Failure With Preserved Ejection Fraction: Pooled Analysis of 3 Clinical Trials - ScienceDirect
Recent Randomised Clinical Trials of Seven Angiotensin Receptor Blockers | Download Table
Biogen CHARM 252LH301 - Barrow Neurological Institute
Research | Stroke Research Fellowship
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial - The Lancet
Promoting psychosocial wellbeing following stroke using narratives and guided self-determination: a feasibility study – topic of research paper in Psychology. Download scholarly article PDF and read for free on CyberLeninka open science
Frontiers | Cerebral edema after ischemic stroke: Pathophysiology and underlying mechanisms
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial - The Lancet
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial - The Lancet
Acute stroke trials invite patients to participate within a short time period- including up to 12hrs, 72hrs, 96hrs and 120 hours
